Internal Medicine · High Point, NC
NPI
1134107022
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1380 Eastchester Dr Ste 105
High Point, NC, 27265
Phone (336) 610-1300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
87,608 services
Medicare patients, 2024
1,965
Average age 76
Drug cost, 2024
$6.1M
59,833 prescriptions
Company payments, 2025
$2,111
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imran Haque was code 99458 (e&m - miscellaneous), 10,200 times for 704 patients. In total Imran Haque billed 87,608 services in 149 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 10,200 | 704 | $29.26 | $298K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 9,719 | 1,247 | $41.12 | $400K |
| 99457 E&M - Miscellaneous | Office | 5,101 | 704 | $36.30 | $185K |
| 99309 SNF E&M | Facility | 4,061 | 691 | $76.92 | $312K |
| 36410 Vascular | Office | 2,550 | 679 | $11.65 | $30K |
| 84100 Clinical Chemistry | Office | 2,266 | 785 | $4.65 | $11K |
| 84550 Clinical Chemistry | Office | 2,266 | 785 | $4.43 | $10K |
| 83615 Clinical Chemistry | Office | 2,265 | 785 | $5.92 | $13K |
| 82150 Clinical Chemistry | Office | 2,264 | 785 | $6.35 | $14K |
| 83735 Clinical Chemistry | Office | 2,260 | 784 | $6.57 | $15K |
| 80053 Clinical Chemistry | Office | 2,253 | 785 | $10.35 | $23K |
| 84439 Clinical Chemistry | Office | 2,140 | 779 | $8.84 | $19K |
| 84432 Clinical Chemistry | Office | 2,125 | 779 | $15.74 | $33K |
| 84443 Clinical Chemistry | Office | 2,121 | 779 | $16.46 | $35K |
| 83550 Clinical Chemistry | Office | 2,113 | 775 | $8.57 | $18K |
By year: 2022 $1.6M for 46,388 services; 2023 $2.7M for 91,515 services; 2024 $2.8M for 87,608 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84100 Clinical Chemistry | 2,266 | 785 | $4.65 | $11K |
| 84550 Clinical Chemistry | 2,266 | 785 | $4.43 | $10K |
| 83615 Clinical Chemistry | 2,265 | 785 | $5.92 | $13K |
| 82150 Clinical Chemistry | 2,264 | 785 | $6.35 | $14K |
| 83735 Clinical Chemistry | 2,260 | 784 | $6.57 | $15K |
| 80053 Clinical Chemistry | 2,253 | 785 | $10.35 | $23K |
| 84439 Clinical Chemistry | 2,140 | 779 | $8.84 | $19K |
| 84432 Clinical Chemistry | 2,125 | 779 | $15.74 | $33K |
| 84443 Clinical Chemistry | 2,121 | 779 | $16.46 | $35K |
| 83550 Clinical Chemistry | 2,113 | 775 | $8.57 | $18K |
Medicare prescription drug claims, 2024
In 2024, the drug Imran Haque prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,890 prescriptions and refills. In total Imran Haque wrote 59,833 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,890 | 3,547 | 478 | $41K |
| Gabapentin Generic | 1,690 | 1,906 | 307 | $38K |
| Levothyroxine Sodium Generic | 1,560 | 2,084 | 278 | $19K |
| Eliquis Apixaban | 1,524 | 1,546 | 170 | $535K |
| Amlodipine Besylate Generic | 1,475 | 1,771 | 275 | $14K |
| Trazodone Hcl Generic | 1,289 | 1,536 | 232 | $16K |
| Pantoprazole Sodium Generic | 1,226 | 1,551 | 223 | $18K |
| Omeprazole Generic | 1,153 | 1,657 | 251 | $17K |
| Furosemide Generic | 1,121 | 1,448 | 230 | $8,002 |
| Rosuvastatin Calcium Generic | 974 | 1,544 | 210 | $15K |
| Metformin Hcl Generic | 970 | 1,309 | 169 | $9,286 |
| Tamsulosin Hcl Generic | 953 | 1,091 | 160 | $15K |
| Potassium Chloride Generic | 906 | 1,093 | 164 | $20K |
| Lisinopril Generic | 902 | 1,283 | 179 | $8,133 |
| Oxycodone Hcl Generic | 867 | 867 | 100 | $16K |
Brand drugs: 9,860 claims; generic drugs: 49,588 claims; opioid claims: 1,767.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imran Haque $2,111 ($2,111 in general payments such as food, travel and fees) from 32 companies. The largest payer was Abbvie Inc. with $255.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $255 |
| Novo Nordisk Inc NVO | 14 | $221 |
| Eisai Inc. 4523.T | 7 | $155 |
| Pfizer Inc. PFE | 12 | $153 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $132 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $122 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $86.85 |
| Viatris Specialty LLC | 4 | $79.09 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $75.71 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $69.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.